GIANNOLA, Libero Italo
 Distribuzione geografica
Continente #
NA - Nord America 7.483
EU - Europa 3.913
AS - Asia 2.695
SA - Sud America 455
AF - Africa 129
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 4
Totale 14.694
Nazione #
US - Stati Uniti d'America 7.403
SG - Singapore 981
CN - Cina 949
IT - Italia 735
FI - Finlandia 669
UA - Ucraina 631
RU - Federazione Russa 485
BR - Brasile 369
DE - Germania 293
PL - Polonia 283
HK - Hong Kong 280
IE - Irlanda 228
GB - Regno Unito 195
VN - Vietnam 145
FR - Francia 127
SE - Svezia 94
IN - India 75
CI - Costa d'Avorio 68
BE - Belgio 40
KR - Corea 40
RO - Romania 37
TR - Turchia 37
CA - Canada 32
JP - Giappone 32
MX - Messico 32
BD - Bangladesh 26
AR - Argentina 24
CO - Colombia 21
ZA - Sudafrica 20
NL - Olanda 19
CH - Svizzera 17
IR - Iran 16
EU - Europa 14
EC - Ecuador 13
SA - Arabia Saudita 13
ES - Italia 12
IQ - Iraq 12
ID - Indonesia 11
PK - Pakistan 10
VE - Venezuela 10
MA - Marocco 9
PH - Filippine 9
GR - Grecia 8
MY - Malesia 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
TN - Tunisia 7
TW - Taiwan 7
DZ - Algeria 6
PY - Paraguay 6
HU - Ungheria 5
UZ - Uzbekistan 5
AL - Albania 4
AT - Austria 4
CZ - Repubblica Ceca 4
KE - Kenya 4
KZ - Kazakistan 4
LB - Libano 4
LT - Lituania 4
PT - Portogallo 4
UY - Uruguay 4
AU - Australia 3
BG - Bulgaria 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
EE - Estonia 3
IL - Israele 3
JM - Giamaica 3
JO - Giordania 3
KG - Kirghizistan 3
NI - Nicaragua 3
NO - Norvegia 3
NP - Nepal 3
BY - Bielorussia 2
CL - Cile 2
CR - Costa Rica 2
GE - Georgia 2
MU - Mauritius 2
OM - Oman 2
RS - Serbia 2
SN - Senegal 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BW - Botswana 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
KH - Cambogia 1
KI - Kiribati 1
KW - Kuwait 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
Totale 14.691
Città #
Ashburn 817
Fairfield 713
Chandler 594
Singapore 577
Woodbridge 479
Houston 462
Ann Arbor 398
Wilmington 391
Jacksonville 361
Hong Kong 271
Seattle 261
Zgierz 237
Cambridge 229
Dublin 228
Medford 197
Des Moines 194
Beijing 174
Nanjing 174
Moscow 158
Dearborn 124
Boardman 119
Princeton 119
Palermo 100
Los Angeles 89
Tulsa 84
Altamura 74
New York 73
The Dalles 72
Abidjan 68
Dallas 66
Hefei 58
Ho Chi Minh City 51
Buffalo 50
Lawrence 46
Milan 45
Jinan 42
São Paulo 42
Venice 41
Santa Clara 40
Shenyang 40
Nanchang 39
Council Bluffs 37
Brussels 36
Hebei 34
San Diego 34
Hanoi 32
Changsha 30
Tianjin 29
Jiaxing 27
Ludwigshafen am Rhein 27
Columbus 24
Düsseldorf 23
Seongnam 23
Kumar 22
Rome 22
Warsaw 22
London 20
Saint Petersburg 20
Tokyo 19
Zhengzhou 17
Auburn Hills 16
Munich 16
Ankara 15
Helsinki 15
Verona 15
Chicago 14
Norwalk 14
Denver 13
Hangzhou 13
Johannesburg 12
Rio de Janeiro 12
Washington 12
Brooklyn 11
Chennai 11
Frankfurt am Main 11
Montreal 11
Orem 11
Phoenix 11
Redwood City 11
San Jose 11
Seoul 11
Toronto 11
Turku 11
Boston 10
Guangzhou 10
Kraków 10
Orange 10
San Mateo 10
Kunming 9
Poplar 9
Salvador 9
Stockholm 9
Turin 9
Amsterdam 8
Atlanta 8
Belo Horizonte 8
Campinas 8
Falls Church 8
Indiana 8
Kilburn 8
Totale 9.334
Nome #
Carbamazepine transbuccal delivery: the histo-morphological features of reconstituted human oral epithelium and buccal porcine mucosae in the transmucosal permeation 279
Inhibitory effects of N-valproyl-L-tryptophan on high potassium, low calcium and low magnesium-induced CA1 hippocampal epileptiform bursting activity in rat brain slices 243
Medium-Term Culture of Primary Oral Squamous Cell Carcinoma in a Three-Dimensional Model: Effects on Cell Survival Following Topical 5-Fluororacile Delivery by Drug-Loaded Matrix Tablets 243
Acetaldehyde self-administration by a two-bottle choice paradigm: Consequences on emotional reactivity, spatial learning, and memory 233
Effects of gamma-irradiation on trehalose-hydroxyethylcellulose microspheres loaded with vancomycin 231
Aloin delivery on buccal mucosa: ex vivo studies and design of a new locoregional dosing system 230
N-valproyl-l-tryptophan for CNS-targeting: synthesis, characterization and efficacy in vitro studies of a new potential antiepileptic drug 211
Diffusion of naltrexone across reconstituted human oral epithelium and histomorphological features 199
A new delivery system of Clobetasol-17-propionate (lipid loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic-erosive oral lichen planus. A Phase IV, randomized, observer-blinded, parallel group clinical trial, 198
Bioavailability in vivo of naltrexone following transbuccal administration by an electronically-controlled intraoral device: A trial on pigs. 195
Release of naltrexone on buccal mucosa: permeation studies, histological aspects and matrix system design 194
Medium-term culture of normal human oral mucosa: a novel three-dimensional model to study the effectiveness of drugs administration. 193
N-Valproyl-L-Phenylalanine as New Potential Antiepileptic Drug: Synthesis, Characterization and In Vitro Studies on Stability, Toxicity and Anticonvulsant Efficacy 191
Studies on a new potential dopaminergic agent: in vitro BBB permeability, in vivo behavioural effects and molecular docking evaluation 189
Evaluation of Galantamine transbuccal absorption by reconstituted human oral epithelium and porcine tissue as buccal mucosa models: Part I 188
Controlled delivery of naltrexone by an intraoral device:In vivo study on human subjects 185
3D OSCC model: effects following topical 5-FU delivery by drug-loaded tablets 184
Ocular gelling microspheres: in vitro Precorneal retention time and drug permeation through reconstituted corneal epithelium 178
New prospective in treatment of Parkinson’s disease: Studies on permeation of ropinirole through buccal mucosa 178
5-Fluorouracil Buccal Tablets for Locoregional Chemotherapy of Oral Squamous Cell Carcinoma: Formulation, Drug Release and Histological Effects on Reconstituted Human Oral Epithelium and Porcine Buccal Mucosa 177
Assessment of in vivo organ-uptake and in silico prediction of CYP mediated metabolism of DA-Phen, a new dopaminergic agent 172
In situ delivery of corticosteroids for treatment of oral diseases 172
Ambulatory Treatment and Telemonitoring of Patients with Parkinson’s Disease 170
Effects of DA-Phen, a dopamine-aminoacidic conjugate, on alcohol intake and forced abstinence 170
Comparative Study of the Effects Exerted by N-Valproyl-L-Phenylalanine and N-valproyl-L-tryptophan on CA1 Hippocampal Epileptiform Activity in Rat. 168
Human Buccal Mucosa as an Innovative Site of Drug Delivery 165
Physical methods for enhancing oral mucosal delivery: Sonophoresis, iontophoresis and electroporation methods 162
Current status in buccal drug delivery 162
Oral local drug delivery and new perspectives in oral drug formulation 160
New prospectives in the delivery of galantamine for elderly patients using the IntelliDrug intraoral device: in vivo animal studies 155
Potential transbuccal delivery of l-DOPA methylester prodrug: stability in the environment of the oral cavity and ability to cross the mucosal tissue 155
Buccal drug delivery: what’s new and what does the future hold? 153
Small endogenous molecules as moiety to improve targeting of CNS drugs 152
Drug delivery from the oral cavity: focus on a novel mechatronic delivery device 151
Buccal delivery of Methimazole as an alternative means to optimize drug bioavailability: permeation studies and matrix system design 151
A new intraoral device to home assist Parkinson’s disease patients by distant control 150
Is Acetaldehyde a substance of abuse? Evidence from a free-access, three-bottle choice paradigm 149
A three-cell type in vitro-model of BBB 148
Recent Advances in Drug Delivery from the Oral Cavity. Focus on innovative buccal drug delivery devices 146
A NEW DOPAMINE-AMINOACID CONJUGATE: SYNTHESIS AND DETERMINATION OF PHYSICO-CHEMICAL PROPERTIES USEFUL TO CROSS THE BBB 146
Optimization of local delivery of antifungal agents in the oral cavity by a new formulation 145
N-valproyl-aminoacids as new potential antiepileptic drugs: Synthesis, characterization and in vitro studies on stability 144
Buccal delivery in treatment of Alzheimer disease: enhancement of galantamine absorption 141
Galantamine delivery on buccal mucosa: permeation enhancement and design of matrix tablets 140
Buccal delivery as a new challenge for treatment of motor fluctuations in Parkinson's Disease 139
An intraoral drug delivery device for long term therapies: application in Alzheimer’s disease 139
Enteric Aloin loaded microparticles for treatment of colorectal cancer 136
Lipid Phase Transition in Saccharide Coated Cholate containing liposomes: Coupling to the Surrounding Matrix 134
DESIGN AND CHARACTERIZATION OF MUCOADHESIVE SUBLINGUAL FILMS CONTAINING FUROSEMIDE 134
Evaluation of the aptitude to cross the BBB of a new dopamine aminoacidic prodrug 132
A new dopamine amino-acid conjugate: preclinical in vitro studies and evaluation of behavioural effects in rats 132
New horizons for OSCC chemotherapy: transmucosal permeability of 5-fluorouracil throughout porcine buccal mucosa 130
Aloin loaded matrix tablets for topical treatment of oral cancer 130
MEDIUM-TERM CULTURE OF THE NORMAL ORAL MUCOSA: A NOVEL THREE-DIMENSIONAL MODEL TO STUDY THE EFFECTIVENESS OF DRUGS ADMINISTRATION 126
Aminoacidic derivatives as novel CNS-targeted neurotherapeutics 126
CNS-targeted valproic-aminoacid conjugate: preliminary studies on pharmacokinetic parameters and antiepileptic activity 125
5-Fluororacile-loaded matrix tablets for locoregional delivery: effects on a three-dimensional culture model of primary oral squamous cell carcinoma 124
DA-Phen as a new potential DA-mimetic agent for treatment of alcohol addiction: preclinical in vivo studies 124
PARTICELLE MICROMETRICHE, LORO METODO DI PREPARAZIONE E LORO USI 122
DOPAMINE PRO-DRUGS FOR CNS TARGETING: SYNTHESIS, CHARACTERIZATION AND HYDROLYSIS BY BRAIN ENZYMES. 121
Physical methods to promote drug delivery on mucosal tissues of the oral cavity 121
Transbuccal tablets of carbamazepine: formulation, release and absorption pattern 118
AMINOACID PRO-DRUG TO SHUTTLE VALPROIC ACID INTO CNS 118
DA-Phen, a new dopamine aminoacid conjugate: in vivo testing and molecular modeling as dopaminergic modulator 117
Buccal Delivery of Carbamazepine (CBZ): a New Scenario in Menagement of Trigeminal Neuralgia (TN) 117
Transbuccal delivery of l-dopa methyl ester: ex vivo permeation studies 115
Functional feature of a novel model of blood brain barrier: Studies on permeation of test compounds 115
Ex vivo transbuccal delivery of carbamazepine across porcine mucosa 114
Formulation and kinetic studies on matrix tablets loaded with 5-Fluorouracil useful in oral cancer treatment 109
Lipid Phase Transition in Saccharide-Coated Cholate-Containing Liposomes: Coupling to the Surrounding Matrix 109
Trehalose-loaded liposomes to regulate skin moisturization 107
Potential dopamine prodrug-loaded liposomes: preparation, characterization, and in vitro stability studies 107
Electronic buccal drug delivery system to treat addiction and chronic diseases,porcine study in the frame of "Intellidrug"project 106
Neurons and ECM regulate occludin localization in brain endothelial cells 106
Synthesis and in vitro studies on a potential dopamine prodrug 105
N-valplroyl-aminoacids as new potential antiepileptic drugs: synthesis, characterization and in vitro studies on stability 105
Matrix system development, permeation studies and histological features for transbuccal delivery of Naltrexone 102
Ambulante Therapie & Telemonitoring von Patienten mit Parkinson 100
Naltrexone-loaded matrices: preparation, drug release and absorption through reconstituted buccal human epithelium 98
Sintesi, caratterizzazione e studio della stabilità chimica ed enzimatica di nuovi profarmaci della dopamina 97
Inclusion of Trehalose (TRH) into liposomes to regulate uptake of this cryoprotectant into human hepatocytes. 97
Formulazione di sistemi innovativi per la somministrazione di antitumorali per il trattamento del Carcinoma Orale Squamoso 96
Trehalose stabilizing effects on L-DOPA aqueous solutions 92
Electronic buccal drug delivery system to treat addiction and chronic diseases: a porcine study in the frame of "IntelliDrug" project 92
Transbuccal delivery of methimazole: ex vivo permeation studies, histomorphological features and matrix system development 91
Buccal delivery for systemic and local therapies: new in vitro studies 87
Transmucosal delivery della Galantamina attraverso mucosa buccale ex vivo 86
Potential dopamine prodrug-loaded liposomes: preparation, characterization and in vitro stability studies 86
Efficacy of 5-FU topically applied on a buccal mucosal model resembling human tissue. A new chance for OSCC chemotherapy. 86
Progettazione e realizzazione di sistemi di rilascio programmato nella terapia delle ferite da ustione 85
Movement of Galantamine in biological environment and through the membranes 84
Tablets for buccal administration of carbamazepine: comparative behavior of PAA microspheres and matrices 84
Solid and Semisolid Innovative Formulations Containing Miconazole-Loaded Solid Lipid Microparticles to Promote Drug Entrapment into the Buccal Mucosa 84
Dental implant for electronically controlled drug release 81
Clinical Trial and Bioavailability of Naltrexone 80
Modulation of alcohol consumption using an operant self-administration paradigm: effects of a new dopamine aminoacidic conjugate, Phenylalanine-β(3,4dihydroxyphenyl)-etilamide. 80
Iontoforesis and drug absorption through reconstituted buccal human epithelium 79
The Home-based Empowered Living for Parkinson's disease patients 79
Loaded sulfamethoxazole/trimethoprim soft films for treatment of burn wounds. 78
“In vitro studies, emphasis on the preparation of the drugs in matrices”. 77
Totale 13.810
Categoria #
all - tutte 52.150
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.150


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021815 0 0 0 0 0 31 141 69 157 125 138 154
2021/20221.170 40 286 25 32 42 41 45 69 140 130 55 265
2022/20231.687 188 237 28 179 208 275 145 131 202 17 59 18
2023/2024714 28 114 45 58 49 149 52 56 3 13 20 127
2024/20251.800 60 75 157 191 84 29 138 103 81 209 241 432
2025/20262.925 461 147 302 507 621 887 0 0 0 0 0 0
Totale 15.109